Nippon India Pharma Fund-Growth Plan-Growth Option Invest Now
Fund Manager: Sailesh Raj Bhan, Akshay Sharma    |     Equity: Sectoral-Pharma and Healthcare    |     S&P BSE Healthcare TRI

275.5014 -0.86 (-0.31 %)

NAV as on 31-01-2023

4,563.4 Cr

AUM as on 31-12-2022

Rtn ( Since Inception )

19.44%

Inception Date

Jun 01, 2004

Expense Ratio

2.06%

Fund Status

Open Ended Scheme

Min. Investment

5,000

Min. Topup

1,000

Min. SIP Amount

100

Risk Status

very high

Investment Objective : The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.